These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11585288)

  • 1. Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts.
    Kinuya S; Kawashima A; Yokoyama K; Kudo M; Kasahara Y; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Eur J Nucl Med; 2001 Sep; 28(9):1306-12. PubMed ID: 11585288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells.
    Li XF; Kinuya S; Yokoyama K; Koshida K; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1669-74. PubMed ID: 12458402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival of mice bearing liver metastases of colon cancer cells treated with a combination of radioimmunotherapy and antiangiogenic therapy.
    Kinuya S; Yokoyama K; Koshida K; Mori H; Shiba K; Watanabe N; Shuke N; Bai J; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):981-5. PubMed ID: 14991242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts.
    Kinuya S; Kawashima A; Yokoyama K; Koshida K; Konishi S; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    J Nucl Med; 2002 Aug; 43(8):1084-9. PubMed ID: 12163635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy.
    Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Sci; 2003 Jul; 94(7):650-4. PubMed ID: 12841877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment.
    Kinuya S; Yokoyama K; Konishi S; Li XF; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
    Eur J Nucl Med; 2001 Jun; 28(6):750-5. PubMed ID: 11440036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal timing of administration of hyperthermia in combined radioimmunotherapy.
    Kinuya S; Yokoyama K; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2000 Aug; 15(4):373-9. PubMed ID: 11041022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer.
    Kinuya S; Yokoyama K; Izumo M; Sorita T; Obata T; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):392-6. PubMed ID: 14605881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy with 186Re-labeled monoclonal antibody to treat liver metastases of colon cancer cells in nude mice.
    Kinuya S; Yokoyama K; Kawashima A; Izumo M; Sorita T; Obata T; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2002 Dec; 17(6):681-7. PubMed ID: 12537672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts.
    Kinuya S; Yokoyama K; Kawashima A; Hiramatsu T; Konishi S; Shuke N; Watanabe N; Takayama T; Michigishi T; Tonami N
    J Nucl Med; 2000 Jul; 41(7):1244-9. PubMed ID: 10914917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
    Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
    Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W
    Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
    Koppe MJ; Oyen WJ; Bleichrodt RP; Verhofstad AA; Goldenberg DM; Boerman OC
    Cancer Biother Radiopharm; 2006 Oct; 21(5):506-14. PubMed ID: 17105422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
    Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.
    Chalandon Y; Mach JP; Pèlegrin A; Folli S; Buchegger F
    Anticancer Res; 1992; 12(4):1131-9. PubMed ID: 1503403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
    Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
    Pedley RB; Hill SA; Boxer GM; Flynn AA; Boden R; Watson R; Dearling J; Chaplin DJ; Begent RH
    Cancer Res; 2001 Jun; 61(12):4716-22. PubMed ID: 11406542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
    Koppe MJ; Oyen WJ; Bleichrodt RP; Hendriks T; Verhofstad AA; Goldenberg DM; Boerman OC
    Cancer Immunol Immunother; 2006 Jan; 55(1):47-55. PubMed ID: 15868166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
    Sun LQ; Vogel CA; Mirimanoff RO; Coucke P; Slosman DO; Mach JP; Buchegger F
    Cancer Res; 1997 Apr; 57(7):1312-9. PubMed ID: 9102219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.